TrialEuropean journal of drug metabolism and pharmacokinetics2023

Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin

Joel S Owen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.